Navigation Links
Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010
Date:12/16/2009

se II inhibitor with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. Anthracyclines are the cornerstone therapeutic for the treatment of lymphoma, leukemia, and breast cancer. Although they are sufficiently effective to be used as first-line (initial) treatment, they cause cumulative heart damage that may result in congestive heart failure many years later. As a result, there is a lifetime limit of anthracycline doses and most patients who previously have been treated with an anthracycline are not able to receive further anthracycline treatment if their disease returns. It also can be administered through a peripheral vein rather than a central implanted catheter as required for other drugs in this class.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.

Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_alert

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the trading price of the securities of CTI. Specifically, the risks and uncertainties that could affect the development of
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015  Johnson & Johnson (NYSE: JNJ ) ... (Eastern Time) on Thursday, April 23, 2015, from the State ... Investors and other interested parties may access the live ... at www.jnj.com and clicking on the webcast icon. ... be made available a few hours after the live meeting ...
(Date:3/27/2015)... 2015  WebMD Health Corp. (NASDAQ: ... information, today announced an exclusive White House ... Plan for Combating Antibiotic-Resistant Bacteria . During ... and importance of addressing antibiotic-resistant bacteria and ... The WebMD interview, available online ...
(Date:3/26/2015)... March 26, 2015 "Whether it,s our family, ... day." In a single sentence, Dr. ... officer at Pfizer,s Centers for Therapeutic Innovation ... fueling progress at America,s biopharmaceutical companies. ... with academia, patient foundations and the National Institutes of ...
Breaking Medicine Technology:Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2
... Vaccines made in China will now be supplied ... after recognition from the World Health Organisation (WHO) ... has complied with international standards for vaccine regulation. ... precondition that could lead to the UN purchasing ...
... MYL ) today commented on the death of Milan "Mike" ... Mylan Chairman and CEO Robert J. Coury said: "We were deeply ... Mike was a pioneer in many ways and helped to create ... who knew Mike personally will always remember him as a strong ...
Cached Medicine Technology:VacChina 2011 International Conference Meets in Shanghai This November 2
(Date:3/28/2015)... a bite of warm, gooey pepperoni pizza, and your ... stomach, ready to break down your meal. In many ... amok, triggering a burning sensation in the chest. Heartburn ... Americans have heartburn at least once a month. The ... can be stopped. , Heartburn or acid reflux symptoms ...
(Date:3/28/2015)... York, New York (PRWEB) March 28, 2015 ... http://www.vaginalmeshlawsuit2015.com/ ) involving devices manufactured by C.R. Bard, ... litigation underway in U.S. District Court, Southern District ... S. Grand, is serving on the Plaintiffs’ Steering ... 24th, the Court has granted certain defendants named ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Emergency Medical ... urgent care in Manhattan, recently commemorated its three-year anniversary ... in Manhattan. In addition to 24-hour urgent care, Emergency ... , At this time, Emergency Medical Care’s ... pain, asthma, chest pain, eye injuries, ear infections, fevers, ...
(Date:3/28/2015)... New York, NY (PRWEB) March 28, 2015 ... 2015 highlighted a problem which could prove critical to ... Why system testing, a critical aspect of data security, ... payment card industry data security report, every major category ... vulnerability scanning and penetration testing. “With all the craziness ...
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 Pitching speed, ... a history of shoulder and elbow injuries, according to new ... Medicine’s ( AOSSM ) Specialty Day. , “Our findings indicate ... a 20% increase in likelihood of a history of injury, ... with a 12% increase likelihood of a history of injury, ...
Breaking Medicine News(10 mins):Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2
... ... the Southwest chooses HealthWyse based on its track record of improving patient care. ... Wilmington, MA (PRWEB) ... Southwest, of San Antonio, Texas (DSSW) announced today the successful implementation of the HealthWyse ...
... ... Sparsense, the developer of a novel image and ... development services firm. The exclusive partnership will allow the development of ... and other applications. The new technology can be applied to MRI, ...
... , , ... just released findings that reveal: "On average, students in online ... the first study to support the benefits of online education, ... the power of online education. , , ...
... new study from the University of Missouri may shed light on ... elderly. In the study, published in this week,s edition of ... gene therapy with a proven "longevity" gene energized mice during exercise, ... "Aging is one of the biggest challenges to a modern society. ...
... , , HOUSTON, Aug. 19 Cyberonics, Inc. (Nasdaq: ... , Quarterly highlights , Results for the first quarter ... , Net sales of $38.5 million, a 14% increase ... increase of 134% from the $2.8 million reported in the prior year; , ...
... approach cuts ,street, drug use and illegal activities, study ... heroin addicts who were given "medical heroin" were able ... a Canadian study has found. , In addition, rates ... the participants, who had failed earlier attempts at treatment, ...
Cached Medicine News:Health News:Healthwyse Clinical and Financial Software Implemented by Disability Services of the Southwest 2Health News:Healthwyse Clinical and Financial Software Implemented by Disability Services of the Southwest 3Health News:Mantaro Partners with Sparsense to Deliver High Performance Digital Image and Signal Processing Solutions 2Health News:Mantaro Partners with Sparsense to Deliver High Performance Digital Image and Signal Processing Solutions 3Health News:New Study Shows Online Education Superior to Classroom Study 2Health News:Living longer and happier 2Health News:Cyberonics Reports Strong Fiscal 2010 First Quarter Results 2Health News:Cyberonics Reports Strong Fiscal 2010 First Quarter Results 3Health News:Cyberonics Reports Strong Fiscal 2010 First Quarter Results 4Health News:Cyberonics Reports Strong Fiscal 2010 First Quarter Results 5Health News:Cyberonics Reports Strong Fiscal 2010 First Quarter Results 6Health News:Cyberonics Reports Strong Fiscal 2010 First Quarter Results 7Health News:Cyberonics Reports Strong Fiscal 2010 First Quarter Results 8Health News:Cyberonics Reports Strong Fiscal 2010 First Quarter Results 9Health News:Cyberonics Reports Strong Fiscal 2010 First Quarter Results 10Health News:Medical Heroin Helps Treatment-Resistant Addicts 2Health News:Medical Heroin Helps Treatment-Resistant Addicts 3
... a comprehensive pocket-sized reference to ... on the evaluation and management of diseases ... Updated annually. The complete content is available ... for Pocket PC- and Palm-based PDAs are ...
... The AT555 utilizes a patented hands-free ... your staff to take an accurate IOP ... slides the headrest to the left or ... their head against the comfortable headrest pad. ...
... The new Topcon KR-9000PW Wavefront Analyzer ... advanced and complete visual analysis system ... incorporates a full range auto refractometer, ... system, while adding the benefits of ...
The new TOPCON 8800 Series of auto refractors and auto kerato-refractors satisfies the needs of today's demanding eyecare practice !...
Medicine Products: